Armenta Bioscience ApS: Financial statements 2024
CVR: 42358444
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Armenta Bioscience ApS (CVR 42358444) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -434,211 and a net result of DKK -1,393,964 compared with DKK -50,267 the year before. Equity in the 2024 report amounted to DKK 684,384. The solvency ratio was 93.4%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -434,211
- Profit/Loss
- DKK -1,393,964
- Equity
- DKK 684,384
- Total Assets
- DKK 733,101
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -434 t. | -1.4 mio. | 684 t. | 3 |
| 2023 | - | 569 t. | -50 t. | -14 t. | 2 |
| 2022 | - | 7 t. | 7 t. | 36 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of July 15, 2024, Mikkel Skorkjær Kongsfelt has joined the board of directors of Armenta Bioscience ApS.
As of July 15, 2024, David Valbjørn Christensen has joined the board of directors of Armenta Bioscience ApS.
As of July 15, 2024, Katharine Sarah Holland has joined the board of directors of Armenta Bioscience ApS.
As of July 15, 2024, Kempf ApS is registered as an owner of Armenta Bioscience ApS with an ownership share of 5%.
As of July 15, 2024, Niklis Holdings ApS is registered as an owner of Armenta Bioscience ApS with an ownership share of 5%.
As of July 15, 2024, Wallbear Invest ApS is registered as an owner of Armenta Bioscience ApS with an ownership share of 25%.
As of July 15, 2024, Stem Cell ApS is registered as an owner of Armenta Bioscience ApS with an ownership share of 25%.
Armenta Bioscience ApS has published its annual report for 2023. Gross profit came to DKK 568,526, and the net result was DKK -50,267.
As of February 12, 2024, Josef Christensen has stepped down as director of Armenta Bioscience ApS.
About Armenta Bioscience ApS
Armenta Bioscience ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Gephion Bio ApS and Meat Tomorrow ApS. The management consists of Matias Heide Ankjær and David Valbjørn Christensen. The company's owners include Accelerace Invest II K/S, Kempf ApS and Niklis Holdings ApS. In 2025, the company reported a gross profit of DKK -676,873 and a net result of DKK -1,433,453 compared with DKK -1,393,964 the year before. Equity in the 2025 report amounted to DKK 1,283,993.